Imatinib
8 NDCs across 3 manufacturers|8 Generic,0 Brand
Imatinib is used to treat blast crisis, dermatofibrosarcoma, gastrointestinal neoplasms, hypereosinophilic syndrome, lymphoid leukemia and myeloid leukemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Imatinib is available as 8 NDCs from 3 manufacturers (8 generic, 0 brand), with NADAC prices from $0.62 to $2.77 per EA — the most expensive product costs about 4.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
8G / 0B
Manufacturers
3
competing in market
Price Spread
$0.62 – $2.77
per EA
7d Activity
avg -2.4% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Kinase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing IMATINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
IMATINIB MESYLATE 400 MG TAB | $2.7670 per EA | — |
IMATINIB MESYLATE 400 MG TAB | $2.6771 per EA | -6.93% |
IMATINIB MESYLATE 400 MG TAB | $2.6771 per EA | -6.93% |
IMATINIB MESYLATE 400 MG TAB | $2.6771 per EA | -6.93% |
IMATINIB MESYLATE 100 MG TAB | $0.8838 per EA | — |
IMATINIB MESYLATE 100 MG TAB | $0.6243 per EA | +2.12% |
IMATINIB MESYLATE 100 MG TAB | $0.6243 per EA | +2.12% |
IMATINIB MESYLATE 100 MG TAB | $0.6243 per EA | +2.12% |
Frequently Asked Questions
What is Imatinib used to treat?
Imatinib is used to treat blast crisis, dermatofibrosarcoma, gastrointestinal neoplasms, hypereosinophilic syndrome, lymphoid leukemia and myeloid leukemia, per the National Library of Medicine's MED-RT classification.
How many Imatinib products are on the market?
The Imatinib drug market contains 8 NDCs from 3 manufacturers — 8 generic and 0 brand products.
What is the price range for Imatinib?
NADAC reference prices for Imatinib range from $0.6243 to $2.7670 per EA — the most expensive product costs about 4.4× the cheapest.
Which manufacturers make Imatinib?
3 manufacturers list Imatinib in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (4), Mylan Institutional LLC (2), Mylan Pharmaceuticals Inc. (2).
How has the price of Imatinib changed recently?
Over the past 7 days, 3 Imatinib NDCs rose and 3 fell, with a market-wide average change of -2.4%.